Medication-assisted weight loss in the moderate range is up to approximately 25% of body weight for many patients
One additional effect of the drug is keeping patients feeling full for longer
Clinical Evidence The SURMOUNT-1 [1] retatrutide trial [2] demonstrated that 87% of participants experienced significant reduction in sweet food cravings within 28 days
Studies show that to achieve comparable clinical effects, oral semaglutide doses are typically 5 to 10 times higher than injectable doses
Moreover, vitamin C promotes the formation of collagen , which is the connective tissue that supports arterial walls, skin, bones, and teeth
And thats exactly where medical weight loss therapies like GLP-1, GIP, and GLP-3 come in